Make scientific figures in minutes

Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software

search icon
arrow-right
Use Icons In The App

Try a synonym, or sign up to request an icon from the app.

Adult female (stage III abdominal obesity)

Adult female (stage III abdominal obesity) - Editable icon of An adult female with stage III abdominal obesity, viewed from the anterior front side in anatomical position
[{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2a1/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2a1/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2a2/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2a2/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2a3/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2a3/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2a4/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2a4/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2a5/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2a5/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2a6/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2a6/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2a7/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2a7/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2a8/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2a8/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2a9/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2a9/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2aa/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2aa/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2ab/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2ab/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2ac/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2ac/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2ad/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2ad/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2ae/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2ae/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2af/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2af/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2b0/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2b0/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2b1/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2b1/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2b2/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2b2/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2b3/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2b3/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2b4/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2b4/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2b5/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2b5/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2b6/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2b6/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2b7/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2b7/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2b8/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2b8/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2b9/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2b9/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2ba/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2ba/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2bb/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2bb/663cdd412503f75db368e266.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cdd8c2503f75db368e2bc/663cdd412503f75db368e266.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cdd8c2503f75db368e2bc/663cdd412503f75db368e266.png"}]
Keywords
female obesity,obese female,obese woman,stage III obesity,stage 3 obesity,stage III,abdominal obesity,visceral obesity,central obesity,fat female,fat woman,overweight female,overweight woman,overweight,body mass index,high BMI,BMI,fat,obesity,obese,chubby,large size,fatness,II,insulin,diabetes,hypertension,adult female,human body woman,person,body,people,figure,female,woman,girl,gal,face,eyes open,hair,standing,stand,stood,back,head,limbs,arm,leg,hand,foot,feet,adult,mature,grown,full-grown,young adult,middle adult,old adult,anterior,frontal,front view,anterior view,front,anatomical position,nude,naked,without clothes,unclothed,obese,obesity,overweight,fat
Image types

Adult female (stage III abdominal obesity) icon JPEG

Adult female (stage III abdominal obesity) icon PNG

Adult female (stage III abdominal obesity) icon SVG

Adult female (stage III abdominal obesity) icon GIF

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today
SIGN UP FREE
Decorative Chat Icon

FAQ

What is BioRender?
BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Adult female (stage III abdominal obesity) icon along with our library of more than 30,000 life science icons.
Can I use this icon in a BioRender figure or scientific illustration?
Yes, the Adult female (stage III abdominal obesity) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.
Is the Adult female (stage III abdominal obesity) icon customizable in BioRender?
Most icons in BioRender, including the Adult female (stage III abdominal obesity) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.
How are scientists using the Adult female (stage III abdominal obesity) icon in their work?
BioRender users often use the Adult female (stage III abdominal obesity) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Human Anatomy.
Can I export figures that include the Adult female (stage III abdominal obesity) icon for publication or presentations?
Yes, figures containing the Adult female (stage III abdominal obesity) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.
Is the Adult female (stage III abdominal obesity) icon used in BioRender templates or poster layouts?
Many BioRender templates include icons like the Adult female (stage III abdominal obesity) icon — especially those focused on Human Anatomy. You can search BioRender’s template library or add this icon manually to any canvas.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now